Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,270 publicly listed stocks with a combined market cap of $1.89 Trillion. Nektar Therapeutics leads the sector with a market cap of $2.03 Billion. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.89 Trillion
Companies Listed
1,270
Largest Company
Nektar Therapeutics
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 151 |
Nektar Therapeutics
NASDAQ:NKTR |
$2.03 Billion | $2.03 Billion | USA | $60.27 | -1.43% | +6.45% | 22.15 Million |
| 152 |
Immunome Inc
NASDAQ:IMNM |
$2.03 Billion | $2.03 Billion | USA | $17.91 | -0.89% | -3.76% | 29.04 Million |
| 153 |
Jinyu Bio-Technology Co Ltd
SHG:600201 |
$2.01 Billion | CN¥13.76 Billion | China | CN¥12.38 | -0.80% | +4.47% | 710.05 Million |
| 154 |
Zai Lab Ltd
NASDAQ:ZLAB |
$1.99 Billion | $1.99 Billion | USA | $17.73 | +0.00% | +7.58% | 22.22 Million |
| 155 |
Mineralys Therapeutics, Inc. Common Stock
NASDAQ:MLYS |
$1.98 Billion | $1.98 Billion | USA | $23.99 | +0.29% | +6.62% | 44.43 Million |
| 156 |
Kodiak Sciences Inc
NASDAQ:KOD |
$1.94 Billion | $1.94 Billion | USA | $32.94 | -3.29% | +11.25% | 15.91 Million |
| 157 |
ADMA Biologics Inc
NASDAQ:ADMA |
$1.90 Billion | $1.90 Billion | USA | $8.58 | +0.94% | +6.45% | 79.75 Million |
| 158 |
Anhui Anke BioTech Group
SHE:300009 |
$1.90 Billion | CN¥12.97 Billion | China | CN¥7.76 | -0.89% | -2.39% | 322.82 Million |
| 159 |
Trevi Therapeutics Inc
NASDAQ:TRVI |
$1.89 Billion | $1.89 Billion | USA | $15.40 | +5.05% | +14.07% | 26.95 Million |
| 160 |
Galapagos NV ADR
NASDAQ:GLPG |
$1.89 Billion | $1.89 Billion | USA | $28.68 | -1.58% | -1.65% | 4.67 Million |
| 161 |
Harmony Biosciences Holdings
NASDAQ:HRMY |
$1.86 Billion | $1.86 Billion | USA | $33.83 | -1.02% | +4.45% | 18.04 Million |
| 162 |
ZAI LAB LTD0000006
F:1ZLB |
$1.82 Billion | €1.56 Billion | Germany | €1.52 | +2.01% | +7.80% | 0.00 |
| 163 |
Rapport Therapeutics, Inc. Common Stock
NASDAQ:RAPP |
$1.82 Billion | $1.82 Billion | USA | $38.49 | +0.60% | +4.93% | 6.91 Million |
| 164 |
Pharvaris BV
NASDAQ:PHVS |
$1.82 Billion | $1.82 Billion | USA | $31.46 | -0.25% | -0.41% | 8.00 Million |
| 165 |
Stoke Therapeutics Inc
NASDAQ:STOK |
$1.82 Billion | $1.82 Billion | USA | $29.15 | -2.83% | +0.52% | 12.49 Million |
| 166 |
REMEGEN CO. LTD YC 1
F:REG |
$1.81 Billion | €1.55 Billion | Germany | €7.41 | -5.65% | +2.80% | 0.00 |
| 167 |
Ocular Therapeutix Inc
NASDAQ:OCUL |
$1.79 Billion | $1.79 Billion | USA | $8.94 | -0.56% | +9.56% | 59.50 Million |
| 168 |
Mesoblast Ltd
AU:MSB |
$1.78 Billion | AU$2.52 Billion | Australia | AU$1.95 | -0.26% | -4.88% | 61.24 Million |
| 169 |
Mesoblast Ltd
NASDAQ:MESO |
$1.78 Billion | $1.78 Billion | USA | $13.75 | -0.07% | -0.36% | 3.65 Million |
| 170 |
OliX PharmaceuticalsInc
KQ:226950 |
$1.76 Billion | ₩2.60 Trillion | Korea | ₩129300.00 | +7.04% | +5.64% | 9.15 Million |
| 171 |
MBX Biosciences, Inc. Common Stock
NASDAQ:MBX |
$1.76 Billion | $1.76 Billion | USA | $40.09 | +2.85% | +38.24% | 19.14 Million |
| 172 |
Hugel Inc
KQ:145020 |
$1.75 Billion | ₩2.59 Trillion | Korea | ₩239500.00 | -3.43% | +5.04% | 1.30 Million |
| 173 |
Nanobiotix
NASDAQ:NBTX |
$1.75 Billion | $1.75 Billion | USA | $35.99 | -3.04% | +0.31% | 1.61 Million |
| 174 |
Vericel Corp Ord
NASDAQ:VCEL |
$1.73 Billion | $1.73 Billion | USA | $38.46 | +0.44% | +7.52% | 12.90 Million |
| 175 |
Nurix Therapeutics Inc
NASDAQ:NRIX |
$1.73 Billion | $1.73 Billion | USA | $17.07 | +0.18% | +9.14% | 61.32 Million |
| 176 |
Nuvation Bio Inc
NYSE:NUVB |
$1.72 Billion | $1.72 Billion | USA | $5.12 | -0.39% | +6.67% | 106.07 Million |
| 177 |
Agios Pharm
NASDAQ:AGIO |
$1.71 Billion | $1.71 Billion | USA | $31.84 | +0.06% | +16.03% | 21.65 Million |
| 178 |
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287 |
$1.71 Billion | CN¥11.66 Billion | China | CN¥20.38 | -0.92% | +0.99% | 37.25 Million |
| 179 |
Zymeworks Inc. Common Stock
NASDAQ:ZYME |
$1.68 Billion | $1.68 Billion | USA | $22.49 | -3.31% | -6.02% | 15.14 Million |
| 180 |
Taysha Gene Therapies Inc
NASDAQ:TSHA |
$1.68 Billion | $1.68 Billion | USA | $5.85 | -2.01% | +7.73% | 51.42 Million |
| 181 |
RAPT Therapeutics Inc
NASDAQ:RAPT |
$1.68 Billion | $1.68 Billion | USA | $58.01 | +0.00% | +0.13% | 98.79 Million |
| 182 |
Recursion Pharmaceuticals Inc
NASDAQ:RXRX |
$1.67 Billion | $1.67 Billion | USA | $3.18 | -3.34% | -4.22% | 487.51 Million |
| 183 |
PHARVARIS N.V. EO -12
F:9EN |
$1.67 Billion | €1.43 Billion | Germany | €26.70 | -0.74% | -2.02% | 300.00 |
| 184 |
Sarepta Therapeutics Inc
NASDAQ:SRPT |
$1.67 Billion | $1.67 Billion | USA | $15.78 | +0.06% | +1.48% | 62.22 Million |
| 185 |
Innoviva Inc
NASDAQ:INVA |
$1.66 Billion | $1.66 Billion | USA | $22.61 | +0.85% | +1.25% | 19.75 Million |
| 186 |
Generate Biomedicines, Inc. Common Stock
NASDAQ:GENB |
$1.65 Billion | $1.65 Billion | USA | $13.37 | -1.55% | +4.62% | 20.82 Million |
| 187 |
Viridian Therapeutics Inc
NASDAQ:VRDN |
$1.65 Billion | $1.65 Billion | USA | $15.98 | -1.96% | +1.59% | 39.95 Million |
| 188 |
Syndax Pharmaceuticals Inc
NASDAQ:SNDX |
$1.64 Billion | $1.64 Billion | USA | $18.55 | +0.38% | +9.37% | 39.35 Million |
| 189 |
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
$1.63 Billion | CN¥11.16 Billion | China | CN¥11.74 | -0.76% | -4.32% | 391.71 Million |
| 190 |
Inner Mongolia Furui Med Sci
SHE:300049 |
$1.63 Billion | CN¥11.12 Billion | China | CN¥42.12 | -2.81% | +3.74% | 185.93 Million |
| 191 |
Chengzhi Shareholding Co Ltd
SHE:000990 |
$1.61 Billion | CN¥11.00 Billion | China | CN¥9.05 | +0.11% | -0.22% | 730.32 Million |
| 192 |
Galapagos NV
F:GXEA |
$1.60 Billion | €1.37 Billion | Germany | €24.80 | -1.59% | +2.48% | 172.00 |
| 193 |
Intellia Therapeutics Inc
NASDAQ:NTLA |
$1.59 Billion | $1.59 Billion | USA | $14.55 | -2.48% | +7.86% | 163.20 Million |
| 194 |
Palvella Therapeutics, Inc
NASDAQ:PVLA |
$1.58 Billion | $1.58 Billion | USA | $110.12 | -5.48% | +4.63% | 5.90 Million |
| 195 |
Sionna Therapeutics, Inc. Common Stock
NASDAQ:SION |
$1.56 Billion | $1.56 Billion | USA | $34.75 | -3.47% | +3.70% | 8.30 Million |
| 196 |
Mesoblast Limited
F:LWB |
$1.56 Billion | €1.34 Billion | Germany | €1.14 | -4.32% | -8.76% | 1.50K |
| 197 |
Oruka Therapeutics, Inc.
NASDAQ:ORKA |
$1.56 Billion | $1.56 Billion | USA | $67.71 | -1.67% | +5.70% | 28.08 Million |
| 198 |
Concord Biotech Limited
NSE:CONCORDBIO |
$1.56 Billion | Rs143.83 Billion | India | Rs1374.80 | -0.39% | +14.88% | 13.32 Million |
| 199 |
Abcellera Biologics Inc
NASDAQ:ABCL |
$1.55 Billion | $1.55 Billion | USA | $5.09 | -3.23% | -6.09% | 168.35 Million |
| 200 |
Galapagos N.V.
AS:GLPG |
$1.55 Billion | €1.33 Billion | Netherlands | €24.94 | +2.21% | +5.77% | 1.61 Million |
| 201 |
AnaptysBio Inc
NASDAQ:ANAB |
$1.54 Billion | $1.54 Billion | USA | $57.61 | -3.19% | +12.17% | 12.35 Million |
| 202 |
Tyra Biosciences Inc
NASDAQ:TYRA |
$1.52 Billion | $1.52 Billion | USA | $28.21 | -1.19% | +5.46% | 21.23 Million |
| 203 |
Novavax Inc
NASDAQ:NVAX |
$1.51 Billion | $1.51 Billion | USA | $9.20 | -0.11% | +6.73% | 116.41 Million |
| 204 |
Capricor Therapeutics Inc
NASDAQ:CAPR |
$1.51 Billion | $1.51 Billion | USA | $26.05 | -2.51% | -0.42% | 20.49 Million |
| 205 |
Precigen Inc
NASDAQ:PGEN |
$1.50 Billion | $1.50 Billion | USA | $4.75 | -1.04% | +33.05% | 121.90 Million |
| 206 |
Monte Rosa Therapeutics Inc
NASDAQ:GLUE |
$1.50 Billion | $1.50 Billion | USA | $17.76 | -1.99% | +4.47% | 22.10 Million |
| 207 |
Galecto Inc
NASDAQ:GLTO |
$1.47 Billion | $1.47 Billion | USA | $24.45 | +1.33% | -4.72% | 7.16 Million |
| 208 |
uniQure N.V
F:UQ1 |
$1.46 Billion | €1.25 Billion | Germany | €24.25 | +0.21% | +3.85% | 1.93K |
| 209 |
Uniqure NV
NASDAQ:QURE |
$1.46 Billion | $1.46 Billion | USA | $26.99 | -3.16% | -0.04% | 31.59 Million |
| 210 |
ATAI Life Sciences BV
NASDAQ:ATAI |
$1.45 Billion | $1.45 Billion | USA | $4.14 | +7.81% | +8.66% | 123.13 Million |
| 211 |
Staidson Beijing Biopharma
SHE:300204 |
$1.44 Billion | CN¥9.82 Billion | China | CN¥20.56 | -0.87% | -12.77% | 579.66 Million |
| 212 |
Vir Biotechnology Inc
NASDAQ:VIR |
$1.44 Billion | $1.44 Billion | USA | $8.61 | +0.00% | +1.89% | 37.79 Million |
| 213 |
UroGen Pharma Ltd
NASDAQ:URGN |
$1.43 Billion | $1.43 Billion | USA | $31.95 | +3.52% | +17.25% | 15.54 Million |
| 214 |
Immunocore Holdings Ltd
NASDAQ:IMCR |
$1.42 Billion | $1.42 Billion | USA | $28.17 | -1.61% | +1.37% | 9.55 Million |
| 215 |
ArriVent BioPharma, Inc. Common Stock
NASDAQ:AVBP |
$1.41 Billion | $1.41 Billion | USA | $30.33 | +0.10% | -0.56% | 12.60 Million |
| 216 |
Nanobiotix S.A
PA:NANO |
$1.39 Billion | €1.19 Billion | France | €30.30 | -4.84% | -1.43% | 5.98 Million |
| 217 |
Pharma Mar S.A.
MC:PHM |
$1.38 Billion | €1.18 Billion | Spain | €68.35 | +0.07% | -19.40% | 2.44 Million |
| 218 |
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497 |
$1.38 Billion | CN¥9.42 Billion | China | CN¥17.49 | +0.58% | +11.61% | 624.50 Million |
| 219 |
GH Research PLC
NASDAQ:GHRS |
$1.37 Billion | $1.37 Billion | USA | $19.98 | -1.91% | -0.70% | 5.94 Million |
| 220 |
Ardelyx Inc
NASDAQ:ARDX |
$1.37 Billion | $1.37 Billion | USA | $5.67 | -0.26% | +2.35% | 73.03 Million |
| 221 |
Biohaven Pharmaceutical Holding Co Ltd
NYSE:BHVN |
$1.37 Billion | $1.37 Billion | USA | $12.09 | -0.41% | +8.72% | 65.50 Million |
| 222 |
Inhibrx Biosciences, Inc.
NASDAQ:INBX |
$1.36 Billion | $1.36 Billion | USA | $93.11 | -0.43% | +4.47% | 7.83 Million |
| 223 |
IMMUNOCORE HLDGS ADS/1
F:6YG |
$1.36 Billion | €1.16 Billion | Germany | €24.80 | -1.59% | -7.46% | 4.72K |
| 224 |
Maze Therapeutics, Inc. Common Stock
NASDAQ:MAZE |
$1.32 Billion | $1.32 Billion | USA | $23.86 | -1.69% | +1.19% | 11.76 Million |
| 225 |
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX |
$1.31 Billion | $1.31 Billion | USA | $21.95 | +1.81% | +9.20% | 13.12 Million |
| 226 |
ATAI LIFE SCIENCES BV EO1
F:9VC |
$1.29 Billion | €1.10 Billion | Germany | €3.55 | +0.00% | +4.76% | 69.10K |
| 227 |
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076 |
$1.28 Billion | CN¥8.76 Billion | China | CN¥27.73 | -1.28% | -1.70% | 45.79 Million |
| 228 |
ATAI Life Sciences NV
XETRA:9VC |
$1.27 Billion | €1.09 Billion | Germany | €3.43 | -1.21% | -2.89% | 99.02K |
| 229 |
Vcanbio Cell & Gene Engineering Corp Ltd
SHG:600645 |
$1.27 Billion | CN¥8.68 Billion | China | CN¥18.55 | +0.38% | -1.33% | 234.59 Million |
| 230 |
ABCELLERA BIOLOGICS
F:8QQ |
$1.27 Billion | €1.09 Billion | Germany | €4.40 | -1.01% | -10.39% | 2.97K |
| 231 |
Ascletis Pharma Inc
F:2VJ |
$1.26 Billion | €1.08 Billion | Germany | €1.02 | +0.99% | -6.42% | 1.10K |
| 232 |
immatics biotechnologies GmbH
F:4A3 |
$1.26 Billion | €1.08 Billion | Germany | €8.02 | -2.02% | +0.31% | 1.04K |
| 233 |
MoonLake Immunotherapeutics
NASDAQ:MLTX |
$1.24 Billion | $1.24 Billion | USA | $18.98 | -1.09% | +5.44% | 18.60 Million |
| 234 |
Damora Therapeutics, Inc.
NASDAQ:DMRA |
$1.24 Billion | $1.24 Billion | USA | $20.59 | +2.59% | -1.53% | 8.72 Million |
| 235 |
Tourmaline Bio Inc.
NASDAQ:TRML |
$1.23 Billion | $1.23 Billion | USA | $47.98 | +0.00% | +0.02% | 13.86 Million |
| 236 |
Septerna, Inc. Common Stock
NASDAQ:SEPN |
$1.23 Billion | $1.23 Billion | USA | $35.17 | -2.39% | +15.65% | 7.92 Million |
| 237 |
NANOBIOTIX S.A. SP.ADR
F:5NRA |
$1.21 Billion | €1.04 Billion | Germany | €27.40 | +2.24% | -0.72% | 421.00 |
| 238 |
China Resources Boya Bio pharmaceutical Group Co Ltd
SHE:300294 |
$1.21 Billion | CN¥8.26 Billion | China | CN¥16.39 | -1.68% | +1.42% | 189.67 Million |
| 239 |
Innovita Biological Technology Co. Ltd. A
SHG:688253 |
$1.21 Billion | CN¥8.25 Billion | China | CN¥60.22 | +0.40% | +10.29% | 60.45 Million |
| 240 |
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN |
$1.20 Billion | $1.20 Billion | USA | $28.07 | -2.37% | +0.04% | 6.25 Million |
| 241 |
Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAG |
$1.17 Billion | $1.17 Billion | USA | $25.51 | +1.71% | -0.16% | 4.28 Million |
| 242 |
Chengdu Easton Biopharmaceuticals Co Ltd
SHG:688513 |
$1.17 Billion | CN¥7.96 Billion | China | CN¥45.11 | -0.40% | -1.16% | 41.29 Million |
| 243 |
Starlake Bioscience Co Inc Zhaoqing Guangdong
SHG:600866 |
$1.16 Billion | CN¥7.96 Billion | China | CN¥4.79 | +0.42% | +3.01% | 463.50 Million |
| 244 |
MannKind Corp
NASDAQ:MNKD |
$1.16 Billion | $1.16 Billion | USA | $3.87 | -3.25% | +14.16% | 120.68 Million |
| 245 |
MapLight Therapeutics, Inc. Common Stock
NASDAQ:MPLT |
$1.16 Billion | $1.16 Billion | USA | $27.16 | -2.86% | -7.81% | 6.70 Million |
| 246 |
Neuren Pharmaceuticals Ltd
AU:NEU |
$1.14 Billion | AU$1.62 Billion | Australia | AU$12.77 | -1.39% | -6.45% | 7.30 Million |
| 247 |
Aurisco Pharmaceutical Co Ltd
SHG:605116 |
$1.14 Billion | CN¥7.78 Billion | China | CN¥19.15 | -2.20% | +4.25% | 78.59 Million |
| 248 |
EVEREST MED.LTD DL-0001
F:6HN |
$1.13 Billion | €969.69 Million | Germany | €2.76 | -3.50% | -13.75% | 280.00 |
| 249 |
Day One Biopharmaceuticals Inc
NASDAQ:DAWN |
$1.13 Billion | $1.13 Billion | USA | $21.53 | +0.00% | +0.37% | 36.16 Million |
| 250 |
Aktis Oncology, Inc. Common stock
NASDAQ:AKTS |
$1.12 Billion | $1.12 Billion | USA | $22.63 | +9.38% | +19.29% | 5.04 Million |
| 251 |
Wave Life Sciences Ltd
NASDAQ:WVE |
$1.10 Billion | $1.10 Billion | USA | $5.74 | -4.33% | +0.70% | 88.74 Million |
| 252 |
Zenas BioPharma, Inc. Common Stock
NASDAQ:ZBIO |
$1.10 Billion | $1.10 Billion | USA | $18.19 | -2.78% | +3.29% | 13.72 Million |
| 253 |
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
$1.10 Billion | CN¥7.51 Billion | China | CN¥5.35 | -1.29% | -8.08% | 1.83 Billion |
| 254 |
WAVE LIFE SCIENCES LTD.
F:1U5 |
$1.10 Billion | €938.92 Million | Germany | €4.88 | +1.24% | +1.67% | 0.00 |
| 255 |
180 Life Sciences Corp
NASDAQ:ATNF |
$1.08 Billion | $1.08 Billion | USA | $16.80 | +905.99% | +667.12% | 244.08 Million |
| 256 |
HBM HLDGS LTD DL-000025
F:6XY |
$1.07 Billion | €914.17 Million | Germany | €1.09 | -4.39% | -3.54% | 0.00 |
| 257 |
Eyepoint Pharmaceuticals Inc
NASDAQ:EYPT |
$1.07 Billion | $1.07 Billion | USA | $12.88 | +6.62% | +12.49% | 24.13 Million |
| 258 |
Beijing Hotgen Biotech Co Ltd
SHG:688068 |
$1.06 Billion | CN¥7.23 Billion | China | CN¥77.97 | -3.56% | -1.64% | 49.81 Million |
| 259 |
Savara Inc
NASDAQ:SVRA |
$1.05 Billion | $1.05 Billion | USA | $5.30 | -0.56% | +4.74% | 36.45 Million |
| 260 |
Gempharmatech Co. Ltd. A
SHG:688046 |
$1.05 Billion | CN¥7.14 Billion | China | CN¥17.42 | -2.46% | +0.06% | 104.18 Million |
| 261 |
Shanghai Medicilon Inc
SHG:688202 |
$1.04 Billion | CN¥7.08 Billion | China | CN¥52.71 | +0.59% | +2.73% | 98.04 Million |
| 262 |
Iovance Biotherapeutics Inc
NASDAQ:IOVA |
$1.03 Billion | $1.03 Billion | USA | $3.82 | -5.21% | -4.50% | 294.47 Million |
| 263 |
Idorsia Ltd
SW:IDIA |
$1.03 Billion | CHF814.02 Million | Switzerland | CHF4.51 | -3.10% | +6.82% | 44.64 Million |
| 264 |
Zhejiang Ausun Pharmaceutical Co Ltd
SHG:603229 |
$1.03 Billion | CN¥7.02 Billion | China | CN¥8.45 | +0.60% | -7.24% | 286.32 Million |
| 265 |
DBV Technologies S.A.
PA:DBV |
$1.02 Billion | €874.13 Million | France | €2.95 | -7.34% | +4.01% | 24.56 Million |
| 266 |
Bio-Thera Solutions Ltd
SHG:688177 |
$1.02 Billion | CN¥6.96 Billion | China | CN¥16.80 | -0.59% | -0.59% | 67.60 Million |
| 267 |
Absci Corp
NASDAQ:ABSI |
$1.01 Billion | $1.01 Billion | USA | $7.00 | -3.71% | +6.87% | 110.92 Million |
| 268 |
Ventyx Biosciences Inc
NASDAQ:VTYX |
$1.00 Billion | $1.00 Billion | USA | $14.00 | +0.00% | +0.29% | 71.70 Million |
| 269 |
Verve Therapeutics Inc
NASDAQ:VERV |
$994.04 Million | $994.04 Million | USA | $11.13 | +0.00% | +1.64% | 98.92 Million |
| 270 |
DBV Technologies
NASDAQ:DBVT |
$991.31 Million | $991.31 Million | USA | $16.75 | -7.56% | +4.69% | 6.03 Million |
| 271 |
Gracell Biotechnologies Inc.
NASDAQ:GRCL |
$989.87 Million | $989.87 Million | USA | $500.00 | +0.21% | -3.83% | 75.00K |
| 272 |
Sellas Life Sciences Group Inc
NASDAQ:SLS |
$968.80 Million | $968.80 Million | USA | $7.53 | -2.59% | -5.64% | 258.50 Million |
| 273 |
Blue Jet Healthcare Limited
NSE:BLUEJET |
$957.49 Million | Rs88.54 Billion | India | Rs510.40 | +1.21% | +13.21% | 24.18 Million |
| 274 |
INVENTIVA ADS/1 O.N.
F:6IVA |
$957.19 Million | €818.74 Million | Germany | €4.38 | -0.45% | -2.23% | 102.00 |
| 275 |
Fortrea Holdings Inc.
NASDAQ:FTRE |
$948.95 Million | $948.95 Million | USA | $15.98 | -3.91% | -3.56% | 27.42 Million |
| 276 |
Medincell SA
PA:MEDCL |
$941.48 Million | €805.30 Million | France | €28.02 | +0.72% | -0.14% | 2.57 Million |
| 277 |
Corvus Pharmaceuticals Inc
NASDAQ:CRVS |
$937.61 Million | $937.61 Million | USA | $11.74 | -1.34% | +5.29% | 42.48 Million |
| 278 |
PATTIES FOODS
F:PH4 |
$930.68 Million | €796.06 Million | Germany | €0.50 | -2.94% | +6.00% | 2.00K |
| 279 |
Jade Biosciences, Inc.
NASDAQ:JBIO |
$921.86 Million | $921.86 Million | USA | $15.53 | -3.54% | +3.67% | 25.39 Million |
| 280 |
Xiangxue Pharmaceutical
SHE:300147 |
$904.76 Million | CN¥6.18 Billion | China | CN¥9.35 | -1.58% | -0.85% | 208.50 Million |
| 281 |
MeiraGTx Holdings PLC
NASDAQ:MGTX |
$898.89 Million | $898.89 Million | USA | $9.71 | -0.41% | +6.82% | 18.45 Million |
| 282 |
Gubra A/S
CO:GUBRA |
$893.38 Million | Dkr5.71 Billion | Denmark | Dkr349.60 | -4.11% | +7.31% | 794.34K |
| 283 |
Pharming Group NV
AS:PHARM |
$891.47 Million | €762.53 Million | Netherlands | €1.09 | -1.40% | -1.49% | 221.78 Million |
| 284 |
Seegene Inc
KQ:096530 |
$890.63 Million | ₩1.31 Trillion | Korea | ₩28500.00 | -0.70% | +4.20% | 12.09 Million |
| 285 |
CureVac NV
F:5CV |
$885.32 Million | €757.26 Million | Germany | €3.91 | -0.61% | +10.78% | 458.08K |
| 286 |
Pharming Group NV
NASDAQ:PHAR |
$883.52 Million | $883.52 Million | USA | $12.51 | -2.38% | -2.27% | 250.24K |
| 287 |
Chengdu Kanghua Biological Products
SHE:300841 |
$879.46 Million | CN¥6.01 Billion | China | CN¥46.25 | +0.87% | +4.88% | 51.11 Million |
| 288 |
Youcare Pharmaceutical Group Co. Ltd. A
SHG:688658 |
$872.50 Million | CN¥5.96 Billion | China | CN¥13.25 | -1.12% | -2.57% | 283.77 Million |
| 289 |
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX |
$871.78 Million | $871.78 Million | USA | $17.97 | +3.04% | +10.93% | 4.95 Million |
| 290 |
ARS Pharmaceuticals, Inc
NASDAQ:SPRY |
$867.89 Million | $867.89 Million | USA | $9.70 | -1.12% | +7.90% | 39.97 Million |
| 291 |
Theravance Biopharma Inc
NASDAQ:TBPH |
$854.78 Million | $854.78 Million | USA | $16.69 | +2.27% | +2.46% | 8.79 Million |
| 292 |
Wuhan Keqian Biology Co Ltd
SHG:688526 |
$852.61 Million | CN¥5.83 Billion | China | CN¥12.50 | -1.42% | +1.63% | 30.16 Million |
| 293 |
Shanghai Haohai Biological Tech Co
SHG:688366 |
$848.07 Million | CN¥5.80 Billion | China | CN¥30.47 | -3.27% | -4.42% | 14.97 Million |
| 294 |
DNA Link Inc
KQ:127120 |
$843.98 Million | ₩1.25 Trillion | Korea | ₩36100.00 | +1.12% | +14.79% | 5.59 Million |
| 295 |
Hangzhou Biotest Biotech Co Ltd
SHG:688767 |
$843.71 Million | CN¥5.77 Billion | China | CN¥38.61 | +3.15% | +8.82% | 76.53 Million |
| 296 |
ALPHAMAB ONCOLO.DL-000002
F:3NK |
$843.61 Million | €721.59 Million | Germany | €0.75 | -1.97% | +0.00% | 0.00 |
| 297 |
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX |
$839.53 Million | $839.53 Million | USA | $1.95 | -0.51% | +3.72% | 49.26 Million |
| 298 |
Janux Therapeutics Inc
NASDAQ:JANX |
$835.49 Million | $835.49 Million | USA | $13.70 | -0.29% | +1.41% | 20.78 Million |
| 299 |
Cullinan Oncology LLC
NASDAQ:CGEM |
$832.76 Million | $832.76 Million | USA | $13.55 | -0.44% | +2.03% | 27.85 Million |
| 300 |
Arbutus Biopharma Corp
NASDAQ:ABUS |
$831.63 Million | $831.63 Million | USA | $4.39 | +1.62% | +3.54% | 35.79 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries